Funds and ETFs Sensus Healthcare, Inc.

Equities

SRTS

US81728J1097

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 01:36:03 2024-05-16 pm EDT 5-day change 1st Jan Change
6.235 USD +1.55% Intraday chart for Sensus Healthcare, Inc. +62.47% +162.29%

ETFs positioned on Sensus Healthcare, Inc.

Name Weight AuM 1st Jan change Investor Rating
0.15% 28 M€ -0.45%
0.08% 25 M€ -1.19% -
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.14 USD
Average target price
9 USD
Spread / Average Target
+46.58%
Consensus
  1. Stock Market
  2. Equities
  3. SRTS Stock
  4. Funds and ETFs Sensus Healthcare, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW